IRON Financial’s Idexx Laboratories IDXX Stock Holding History

IRON Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-893	Closed	-$564K	–	115
2021 Q2	$564K	Buy	893 +212	+31%	+$117K	0.26%	44
2021 Q1	$333K	Buy	+681	New	+$341K	0.18%	69

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IRON Financial's IDXX Position: Q3 2021 in Review

IRON Financial sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 893 shares — an estimated $564K sold.

IRON Financial first reported a position in IDXX in Q1 2021 and held it in 2 quarters. The position peaked at $564K in Q2 2021. 1,058 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

IRON Financial reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
IRON Financial sold 893 Idexx Laboratories shares in Q3 2021, an estimated $564K.
IRON Financial first reported a position in Idexx Laboratories in Q1 2021 and held it in 2 quarters.
IRON Financial's Idexx Laboratories position peaked at $564K in Q2 2021.
1,058 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on IRON Financial's 13F filing for Q3 2021, filed 2 Nov 2021.